Prenetics Global Limited
NASDAQ:PREMedical - Diagnostics & Research
+$0.43 today
- Market cap
- $184.89M
- Beta
- 0.24
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$4.18
Volume 0.82M
Average 0.22M
Income Statement
Follow revenue through to earnings.
Revenue
$92.39M
FY 2025 · Annual
+201.7% YoYOperating Income
-$38.13M
FY 2025 · Annual
Net Income
-$37.71M
FY 2025 · Annual
Income Statement
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.53M | 13.16M | 21.74M | 30.62M | 92.39M |
| Cost of Revenue | 8.93M | 9.55M | 12.91M | 15.22M | 43.6M |
| Gross Profit | 3.6M | 3.62M | 8.83M | 15.4M | 48.79M |
| Gross Margin | 28.7% | 27.5% | 40.6% | 50.3% | 52.8% |
| Research & Development | 6.39M | 5.99M | 11.66M | 10.92M | 5.13M |
| Selling, General & Admin | 53.67M | 64.08M | 49.68M | 55.37M | 79.8M |
| Operating Expenses | 60.26M | 69.64M | 60.74M | 63.54M | 86.92M |
| Depreciation & Amortization | 7.35M | 7.54M | 7.79M | 5.93M | 3.78M |
| EBITDA | (209.16M) | (218.04M) | (47.9M) | (51.57M) | (32.19M) |
| EBITDA Margin | -1668.9% | -1656.3% | -220.3% | -168.4% | -34.8% |
| Operating Income | (56.66M) | (66.02M) | (51.91M) | (48.14M) | (38.13M) |
| Operating Margin | -452.1% | -501.5% | -238.7% | -157.2% | -41.3% |
| Interest Income | 201 | 472K | 3.92M | 2.04M | 1.04M |
| Interest Expense | 42.23K | 242K | 119.66K | 203K | 241K |
| Other Income / Expenses | (159.89M) | (159.8M) | (4.76M) | (9.56M) | 1.92M |
| Income Before Tax | (216.55M) | (225.82M) | (56.67M) | (57.7M) | (36.21M) |
| Pre-Tax Margin | -1727.9% | -1715.4% | -260.6% | -188.4% | -39.2% |
| Income Tax Expense | 2.57M | (245K) | (269.36K) | (7.87M) | 34K |
| Net Income | (174.01M) | (190.45M) | (62.72M) | (46.3M) | (37.71M) |
| Net Margin | -1388.4% | -1446.8% | -288.5% | -151.2% | -40.8% |
| EPS (Basic) | (47.04) | (37.57) | (5.58) | (3.64) | (2.68) |
| EPS (Diluted) | (47.04) | (37.57) | (5.58) | (3.64) | (2.68) |
| 3.7M | 5.07M | 11.25M | 12.71M | 14.05M | |
| 3.7M | 5.07M | 11.25M | 12.71M | 14.05M |
PRE Earnings Waterfall · TTM
NASDAQ:PRE · Revenue to Net Income
Key Ratios
Analysis
$113.7M of revenue converted into -$71.0M of net income for the selected period. Gross margin is 56.2% and net margin is -60.7%, showing how much revenue survives after costs and taxes. EPS is $-4.58, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 5, 2026 | |
| 6-K | 6-K filing | Nov 3, 2026 | |
| 6-K | 6-K filing | Nov 2, 2026 | |
| 6-K | 6-K filing | Oct 13, 2026 |
How much revenue does PRE generate?
Prenetics Global Limited (PRE) reported $92.39M of revenue in fiscal 2025.
Is PRE profitable?
Prenetics Global Limited (PRE) reported -$37.71M of net income, with a net margin of -40.8%.
Continue the stock analysis
Jump to another research area for this company.